Summary

Eligibility
for females ages 18 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at Sacramento, California and other locations
Dates
study started
completion
Principal Investigator
by Melissa C Matulich, MD MAS

Description

Summary

Women currently using or starting a combined oral contraceptive (COC) will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for approximately 12 months to evaluate if they continue the implant, the COC, or both, and to assess bleeding patterns and adverse events.

Official Title

Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive: a Multicenter Trial

Details

Keywords

Contraception, Contraceptive implant, Nexplanon, Combined oral contraceptive, Contraceptive Agents, Etonogestrel, Etonogestrel contraceptive implant

Eligibility

Locations

  • University of California, Davis
    Sacramento California 95817 United States
  • University of Colorado
    Denver Colorado 80045 United States
  • University of Pennsylvania
    Philadelphia Pennsylvania 19104 United States

Lead Scientist at UC Davis

  • Melissa C Matulich, MD MAS
    Assistant Professor of Clinical, Med: Obstetrics & Gynecology, School of Medicine. Authored (or co-authored) 11 research publications

Details

Status
accepting new patients
Start Date
Completion Date
Sponsor
University of California, Davis
ID
NCT04423055
Phase
Phase 4 Contraception Research Study
Study Type
Interventional
Participants
About 120 people participating
Last Updated